Novo Nordisk Balance Sheet Health
Financial Health criteria checks 4/6
Novo Nordisk has a total shareholder equity of DKK120.5B and total debt of DKK57.0B, which brings its debt-to-equity ratio to 47.3%. Its total assets and total liabilities are DKK397.4B and DKK276.9B respectively. Novo Nordisk's EBIT is DKK119.8B making its interest coverage ratio -262.7. It has cash and short-term investments of DKK74.9B.
Key information
47.3%
Debt to equity ratio
DKK 56.97b
Debt
| Interest coverage ratio | -262.7x |
| Cash | DKK 74.88b |
| Equity | DKK 120.52b |
| Total liabilities | DKK 276.92b |
| Total assets | DKK 397.44b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NOVA's short term assets (DKK195.2B) do not cover its short term liabilities (DKK208.4B).
Long Term Liabilities: NOVA's short term assets (DKK195.2B) exceed its long term liabilities (DKK68.6B).
Debt to Equity History and Analysis
Debt Level: NOVA has more cash than its total debt.
Reducing Debt: NOVA's debt to equity ratio has increased from 8.2% to 47.3% over the past 5 years.
Debt Coverage: NOVA's debt is well covered by operating cash flow (207.5%).
Interest Coverage: NOVA earns more interest than it pays, so coverage of interest payments is not a concern.